Employers › Control Delivery Systems
Recordkeeping fees per participant · Eyepoint Pharmaceuticals US, Inc. 401(k) Plan · plan year 2024
$117.57
Higher than 65% of the 14,075 plans $10 to 50M that report it.
= $25,983 / 221
Schedule H, line 2i(3); OTH_RECORDKEEPING_FEES_AMT pos 160; filing 20250909161101NAL0043731122001, received 2025-09-09
participants_with_balance: Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20250909161101NAL0043731122001, received 2025-09-09
Percentiles compare this plan with the Schedule H plans $10 to 50M in assets of the same plan year, excluding final filings; shown only where at least 50 comparable plans report the figure. Plan year 2024-01-01 to 2024-12-31, filing received 2025-09-09.
Administrative expenses excluding investment management, per participant
$117.57
Higher than 49% of the 24,371 plans $10 to 50M that report it.
= $25,983 / 221
derived, admin_expenses (2i(12)) minus invst_mgmt_fees (2i(5)), floored at 0; filing 20250909161101NAL0043731122001, received 2025-09-09
participants_with_balance: Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20250909161101NAL0043731122001, received 2025-09-09
Administrative expenses per participant
$215.72
Higher than 54% of the 25,098 plans $10 to 50M that report it.
= $47,675 / 221
Schedule H, line 2i(12) total administrative expenses; TOT_ADMIN_EXPENSES_AMT pos 109; filing 20250909161101NAL0043731122001, received 2025-09-09
participants_with_balance: Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20250909161101NAL0043731122001, received 2025-09-09
Administrative expenses as a share of assets
0.172%
Higher than 31% of the 25,132 plans $10 to 50M that report it.
= $47,675 / $27,640,512
Schedule H, line 2i(12) total administrative expenses; TOT_ADMIN_EXPENSES_AMT pos 109; filing 20250909161101NAL0043731122001, received 2025-09-09
assets_eoy: Schedule H, Part I line 1f col (b); TOT_ASSETS_EOY_AMT pos 61; filing 20250909161101NAL0043731122001, received 2025-09-09
Employer contributions per participant
$7,486
Higher than 97% of the 24,050 plans $10 to 50M that report it.
= $1,654,394 / 221
Schedule H, Part II line 2a(1)(A); EMPLR_CONTRIB_INCOME_AMT pos 68; filing 20250909161101NAL0043731122001, received 2025-09-09
participants_with_balance: Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20250909161101NAL0043731122001, received 2025-09-09
Employer share of total contributions
28.7%
Higher than 53% of the 24,084 plans $10 to 50M that report it.
= $1,654,394 / $5,763,730
Schedule H, Part II line 2a(1)(A); EMPLR_CONTRIB_INCOME_AMT pos 68; filing 20250909161101NAL0043731122001, received 2025-09-09
total_contrib: Schedule H, line 2a(3); TOT_CONTRIB_AMT pos 72; filing 20250909161101NAL0043731122001, received 2025-09-09
Plan terms are not published in public filings.
2F ERISA 404(c) plan · 2E profit-sharing · 2G fully participant-directed · 2J 401(k) feature · 2K 401(m) arrangement · 2T default investment (QDIA) · 3D IRS pre-approved plan · 2R participant brokerage window · Form 5500, line 8a; TYPE_PENSION_BNFT_CODE pos 81; filing 20250909161101NAL0043731122001, received 2025-09-09
| Field | Value | Source |
|---|---|---|
| Plan sponsor | EYEPOINT PHARMACEUTICALS US, INC. | Form 5500, Part II line 2a; SPONSOR_DFE_NAME pos 19; filing 20250909161101NAL0043731122001, received 2025-09-09 |
| Plan name | EYEPOINT PHARMACEUTICALS US, INC. 401(K) PLAN | Form 5500, line 1a; PLAN_NAME pos 16; filing 20250909161101NAL0043731122001, received 2025-09-09 |
| Sponsor EIN / plan number | 06-1357485 / 001 | Form 5500, line 2b; SPONS_DFE_EIN pos 44; filing 20250909161101NAL0043731122001, received 2025-09-09 |
| Plan type | single-employer | Form 5500, Part I line A; TYPE_PLAN_ENTITY_CD pos 4; filing 20250909161101NAL0043731122001, received 2025-09-09 |
| Sponsor location | WATERTOWN, MA | Form 5500, line 2a; SPONS_DFE_MAIL_US_STATE pos 25; filing 20250909161101NAL0043731122001, received 2025-09-09 |
| Industry (business code) | 541990, Professional, scientific, and technical services | Form 5500, line 2d; BUSINESS_CODE pos 46; filing 20250909161101NAL0043731122001, received 2025-09-09 |
| Plan year | 2024-01-01 to 2024-12-31 | Form 5500, Part I plan year; FORM_PLAN_YEAR_BEGIN_DATE pos 2; filing 20250909161101NAL0043731122001, received 2025-09-09 |
| Filing received | 2025-09-09 | Form 5500, EFAST2 receipt date; DATE_RECEIVED pos 102; filing 20250909161101NAL0043731122001, received 2025-09-09 |
| Final filing | no | Form 5500, Part I line B; FINAL_FILING_IND pos 8; filing 20250909161101NAL0043731122001, received 2025-09-09 |
| Amended filing | no | Form 5500, Part I line B; AMENDED_IND pos 7; filing 20250909161101NAL0043731122001, received 2025-09-09 |
| Participants, beginning of year | 188 | Form 5500, line 5; TOT_PARTCP_BOY_CNT pos 71; filing 20250909161101NAL0043731122001, received 2025-09-09 |
| Active participants | 169 | Form 5500, line 6a(2); TOT_ACTIVE_PARTCP_CNT pos 72; filing 20250909161101NAL0043731122001, received 2025-09-09 |
| Participants, end of year | 237 | Form 5500, line 6f; TOT_ACT_RTD_SEP_BENEF_CNT pos 77; filing 20250909161101NAL0043731122001, received 2025-09-09 |
| Participants with an account balance | 221 | Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20250909161101NAL0043731122001, received 2025-09-09 |
| Total assets, beginning of year | $22,358,068 | Schedule H, Part I line 1f col (a); TOT_ASSETS_BOY_AMT pos 30; filing 20250909161101NAL0043731122001, received 2025-09-09 |
| Total assets, end of year | $27,640,512 | Schedule H, Part I line 1f col (b); TOT_ASSETS_EOY_AMT pos 61; filing 20250909161101NAL0043731122001, received 2025-09-09 |
| Net assets, end of year | $27,640,512 | Schedule H, line 1l col (b); NET_ASSETS_EOY_AMT pos 67; filing 20250909161101NAL0043731122001, received 2025-09-09 |
| Total income | $8,895,680 | Schedule H, Part II line 2d; TOT_INCOME_AMT pos 97; filing 20250909161101NAL0043731122001, received 2025-09-09 |
| Net income | $5,282,444 | Schedule H, line 2k; NET_INCOME_AMT pos 111; filing 20250909161101NAL0043731122001, received 2025-09-09 |
| Employer contributions | $1,654,394 | Schedule H, Part II line 2a(1)(A); EMPLR_CONTRIB_INCOME_AMT pos 68; filing 20250909161101NAL0043731122001, received 2025-09-09 |
| Participant contributions | $2,470,245 | Schedule H, line 2a(1)(B); PARTICIPANT_CONTRIB_AMT pos 69; filing 20250909161101NAL0043731122001, received 2025-09-09 |
| Other contributions (incl. rollovers) | $1,639,091 | Schedule H, line 2a(1)(C); OTH_CONTRIB_RCVD_AMT pos 70; filing 20250909161101NAL0043731122001, received 2025-09-09 |
| Total contributions | $5,763,730 | Schedule H, line 2a(3); TOT_CONTRIB_AMT pos 72; filing 20250909161101NAL0043731122001, received 2025-09-09 |
| Benefit payments | $3,565,561 | Schedule H, line 2e(4); TOT_DISTRIB_BNFT_AMT pos 101; filing 20250909161101NAL0043731122001, received 2025-09-09 |
| Total expenses (incl. benefit payments) | $3,613,236 | Schedule H, line 2j; TOT_EXPENSES_AMT pos 110; filing 20250909161101NAL0043731122001, received 2025-09-09 |
| Total administrative expenses | $47,675 | Schedule H, line 2i(12) total administrative expenses; TOT_ADMIN_EXPENSES_AMT pos 109; filing 20250909161101NAL0043731122001, received 2025-09-09 |
| Contract administrator fees | $0 | Schedule H, line 2i(2); CONTRACT_ADMIN_FEES_AMT pos 106; filing 20250909161101NAL0043731122001, received 2025-09-09 |
| Recordkeeping fees | $25,983 | Schedule H, line 2i(3); OTH_RECORDKEEPING_FEES_AMT pos 160; filing 20250909161101NAL0043731122001, received 2025-09-09 |
| IQPA audit fees | $0 | Schedule H, line 2i(4); IQPA_AUDIT_FEES_AMT pos 161; filing 20250909161101NAL0043731122001, received 2025-09-09 |
| Investment advisory and management fees | $21,692 | Schedule H, line 2i(5); INVST_MGMT_FEES_AMT pos 107; filing 20250909161101NAL0043731122001, received 2025-09-09 |
| Administrative expenses excluding investment management | $25,983 | derived, admin_expenses (2i(12)) minus invst_mgmt_fees (2i(5)), floored at 0; filing 20250909161101NAL0043731122001, received 2025-09-09 |
| Held in master trusts | $0 | Schedule H, line 1c(11) col (b); INT_MASTER_TR_EOY_AMT pos 53; filing 20250909161101NAL0043731122001, received 2025-09-09 |
| Held in common/collective trusts | $15,218,741 | Schedule H, line 1c(9) col (b); INT_COMMON_TR_EOY_AMT pos 51; filing 20250909161101NAL0043731122001, received 2025-09-09 |
| Held in mutual funds | $11,522,103 | Schedule H, line 1c(13) col (b); INT_REG_INVST_CO_EOY_AMT pos 55; filing 20250909161101NAL0043731122001, received 2025-09-09 |
| Independent auditor | BERNARD ROBINSON AND COMPANY LLP | Schedule H, Part III line 3a; ACCOUNTANT_FIRM_NAME pos 116; filing 20250909161101NAL0043731122001, received 2025-09-09 |
Position = column in the DOL layout for form year 2024. Filing 20250909161101NAL0043731122001, received 2025-09-09.
| Provider | Relationship | Service codes | Direct compensation | Indirect |
|---|---|---|---|---|
| FIDELITY INVESTMENTS INSTITUTIONALrecordkeeper | RECORDKEEPER | 37 Participant loan processing; 60 Sub-transfer agency fees; 64 Recordkeeping fees; 65 Account maintenance fees | $25,983 | yes |
| CREATIVE PLANNING LLC | ADVISOR | 27 Investment advisory (plan) | $15,598 | no |
| STRATEGIC ADVISORS, INC. | ADVISOR | 27 Investment advisory (plan) | $6,094 | no |
Schedule C Part I line 2: name (a), service codes (b), relationship (c), direct compensation paid by the plan (d), indirect compensation received (e). Filing 20250909161101NAL0043731122001, received 2025-09-09.
| Figure | 2023 | 2024 | Change |
|---|---|---|---|
| Total assets | $22,358,068 | $27,640,512 | 23.6% |
| Participants with a balance | 177 | 221 | 24.9% |
| Administrative expenses | $42,867 | $47,675 | 11.2% |
| Recordkeeping fees per participant | $132.75 | $117.57 | -11.4% |
| Employer contributions | $1,432,258 | $1,654,394 | 15.5% |
Prior filing 20241002082423NAL0008515425001, received 2024-10-02; the plan years are contiguous.
Sponsor name as filed: EYEPOINT PHARMACEUTICALS US, INC.; SEC registrant: CONTROL DELIVERY SYSTEMS INC/MA (CIK 1123959, matched by EIN).